Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy

被引：29
|
作者：
Kouri, M
Kankaanranta, L
Seppälä, T
Tervo, L
Rasilainen, M
Minn, H
Eskola, I
Vähätalo, J
Paetau, A
Savolainen, S
Auterinen, I
Jääskeläinen, J
Joensuu, H
机构：
[1] Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Huch, Finland
[2] Univ Helsinki, Cent Hosp, Dept Lab Diagnost, FIN-00029 Huch, Finland
[3] Univ Helsinki, Cent Hosp, Dept Pharm, FIN-00029 Huch, Finland
[4] Univ Helsinki, Cent Hosp, Dept Pharmacol, FIN-00029 Huch, Finland
[5] Univ Helsinki, Cent Hosp, Dept Neurosurg, FIN-00029 Huch, Finland
[6] Univ Helsinki, Cent Hosp, Dept Radiol, FIN-00029 Huch, Finland
[7] Univ Helsinki, Dept Phys Sci, Helsinki, Finland
[8] Univ Helsinki, Lab Radiochem, Helsinki, Finland
[9] Univ Turku, Dept Radiotherapy & Oncol, Turku, Finland
[10] Univ Turku, Turku PET Ctr, Turku, Finland
[11] Tech Res Ctr Finland, VTT Proc, FIN-02044 Espoo, Finland
[12] Boneca Corp, FIN-00290 Helsinki, Finland
来源：
RADIOTHERAPY AND ONCOLOGY | 2004年 / 72卷 / 01期
基金：
芬兰科学院;
关键词：
boron neutron capture therapy; head and neck carcinoma; sinonasal carcinoma; boronophenylalanine; positron emission tomography;
D O I：
10.1016/j.radonc.2004.03.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A large, rapidly progressing, unresectable undifferentiated sinonasal head and neck carcinoma regressed rapidly following single fraction boron neutron capture therapy (BNCT). The main toxicity consisted of mucositis lasting for a few days. The quality of life improved and was excellent until tumour recurrence 6 months after the date of BNCT. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：83 / 85
页数：3
相关论文
共 50 条
  • [21] Synthesis and evaluation of boron folates for Boron-Neutron-Capture-Therapy (BNCT)
    Kettenbach, Kathrin
    Schieferstein, Hanno
    Grunewald, Catrin
    Iffland, Dorothee
    Reffert, LauraM.
    Hampel, Gabriele
    Schuetz, Christian L.
    Bings, Nicolas H.
    Ross, Tobias L.
    RADIOCHIMICA ACTA, 2015, 103 (11) : 799 - 809
  • [22] An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme
    Pellettieri, L.
    H-Stenstam, B.
    Rezaei, A.
    Giusti, V.
    Skold, K.
    ACTA NEUROLOGICA SCANDINAVICA, 2008, 117 (03): : 191 - 197
  • [23] Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas
    Miyatake, Shin-Ichi
    Kawabata, Shinji
    Nonoguchi, Naosuke
    Yokoyama, Kunio
    Kuroiwa, Toshihiko
    Matsui, Hideki
    Ono, Koji
    NEURO-ONCOLOGY, 2009, 11 (04) : 430 - 436
  • [24] Boron neutron capture therapy for brain tumors
    Yamamoto, Tetsuya
    Tsuboi, Koji
    Nakai, Kei
    Kumada, Hiroaki
    Sakurai, Hideyuki
    Matsumura, Akira
    TRANSLATIONAL CANCER RESEARCH, 2013, 2 (02) : 80 - 86
  • [25] Recent developments in boron neutron capture therapy
    Kabalka, GW
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (05) : 545 - 551
  • [26] Boron Neutron Capture Therapy - A Literature Review
    Nedunchezhian, Kavitaa
    Aswath, Nalini
    Thiruppathy, Manigandan
    Thirugnanamurthy, Sarumathi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (12) : ZE1 - ZE4
  • [27] Reporting Dose in Boron Neutron Capture Therapy
    Sauerwein, Wolfgang A. G.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2023, 38 (03) : 192 - 194
  • [28] Experience of boron neutron capture therapy in Japan
    Kanda, K
    ADVANCES IN NEUTRON CAPTURE THERAPY, VOLS I AND II: VOL I: MEDICINE AND PHYSICS, VOL II: CHEMISTRY AND BIOLOGY, 1997, 1132 : A71 - A76
  • [29] Overview of Boron Neutron Capture Therapy in 2022
    Sauerwein, Wolfgang A. G.
    Ulcar, Miha
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2023, 38 (03) : 143 - 147
  • [30] Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
    Miyatake, Shin-Ichi
    Kawabata, Shinji
    Hiramatsu, Ryo
    Furuse, Motomasa
    Kuroiwa, Toshihiko
    Suzuki, Minoru
    RADIATION ONCOLOGY, 2014, 9
12345